![Jonathan DiVincenzo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan DiVincenzo
Corporate Officer/Principal presso LABCORP HOLDINGS INC.
Patrimonio netto: 1 M $ in data 31/05/2024
Profilo
Mr. Jonathan DiVincenzo is a President-Central Laboratories & International at Laboratory Corp.
of America Holdings.
He is on the Board of Directors at Analytical Life Science & Diagnostics Association.
Mr. DiVincenzo was previously employed as a President, Chief Executive Officer & Director by Enzymatics, Inc. (Massachusetts), a President-Bioscience Division by EMD Millipore Corp., a Member-Innovation by CEB, Inc., and a President-Environmental Health & Senior VP by Revvity, Inc. He received his undergraduate degree from Northeastern University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
0.01% | 27/03/2024 | 5 460 ( 0.01% ) | 1 M $ | 31/05/2024 |
Posizioni attive di Jonathan DiVincenzo
Società | Posizione | Inizio |
---|---|---|
LABCORP HOLDINGS INC. | Corporate Officer/Principal | 01/10/2019 |
Analytical Life Science & Diagnostics Association | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jonathan DiVincenzo
Società | Posizione | Fine |
---|---|---|
QIAGEN Beverly LLC
![]() QIAGEN Beverly LLC BiotechnologyHealth Technology Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A. | Amministratore Delegato | - |
CEB INC | Corporate Officer/Principal | - |
REVVITY, INC. | Corporate Officer/Principal | - |
EMD Millipore Corp.
![]() EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Corporate Officer/Principal | - |
Formazione di Jonathan DiVincenzo
Northeastern University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
REVVITY, INC. | Health Technology |
Aziende private | 5 |
---|---|
EMD Millipore Corp.
![]() EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
QIAGEN Beverly LLC
![]() QIAGEN Beverly LLC BiotechnologyHealth Technology Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A. | Health Technology |
CEB, Inc.
![]() CEB, Inc. Miscellaneous Commercial ServicesCommercial Services CEB, Inc. operates as an insight and technology company. Its solutions include function and people management. The firm serves the financial services, government, and professional services. The company was founded by David G. Bradley in 1983 and is headquartered in Arlington, VA. | Commercial Services |
Analytical Life Science & Diagnostics Association | |
Laboratory Corp. of America Holdings
![]() Laboratory Corp. of America Holdings Medical/Nursing ServicesHealth Services Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC. | Health Services |
- Borsa valori
- Insiders
- Jonathan DiVincenzo